Journal profile

Malaysian Journal of Pharmaceutical Sciences

ISSN 1675-7319 · eISSN 2180-429X · Universiti Sains Malaysia · Malaysia

Malaysian Journal of Pharmaceutical Sciences: diamond open access (no APC); no APC; review about 20 weeks (community reports); 6 articles in 2025.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartile—No CiteScore rank
Review timeabout 20 weeksCommunity average
APCNo APCDiamond open access (no APC)
Acceptance—No reports yet
Articles per year62025 · OpenAlex count

Scope

Aims, scope and focus

Malaysian Journal of Pharmaceutical Sciences is published by Universiti Sains Malaysia. By OpenAlex counts of its recent articles, its largest topics are Pharmacy and Medical Practices, Medicinal Plant Research and Pharmaceutical Practices and Patient Outcomes, together about 39.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Malaysian Journal of Pharmaceutical Sciences provides a platform for academics, researchers and pharmacists from Malaysia and around the world to communicate and share research findings and insight in the fields of pharmacy and pharmaceutical research. Established in 2003, the journal publishes original, scholarly contributions in the form of original research articles, limited number of short communications and reviews.

From the journal's Aims & Scope

Editorial board by country: 1 in mainland China (about 4%); most named Malaysia 9, United Kingdom 2, Indonesia 2, Mainland China 1, Japan 1 (23 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics16.9%
  2. Medicinal Plant ResearchAgricultural and Biological Sciences12.8%
  3. Pharmaceutical Practices and Patient OutcomesMedicine9.5%
  4. Analytical Methods in PharmaceuticalsChemistry5.4%
  5. Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance4.7%
  6. Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics4.1%
  7. Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics4.1%
  8. Diabetes Treatment and ManagementMedicine3.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

DOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

CAB AbstractsPublisher website

Other: ProQuest, EBSCO, Ulrich, Academic Journals Database, EBSCOHost, MyCITE, OALib, MyAIS

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

h-index
8OpenAlex ·
i10-index
7OpenAlex ·
2-year mean citedness
0.29OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 127 in total · the current year is incomplete

YearArticlesOpen accessCitations
20267717
20256627
2024181835
2023161621
2022242419
2021242418

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 20 weeksLetPub ·
Submission to publication (journal-reported)
about 20 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Diamond open access (no APC)DOAJ

Every article is open access and authors pay no article processing charge.

SourceAPCFee waiverLicenseObserved
DOAJNo APCNoCC BY
LetPubNo APCNo—
Publisher websiteNo APC——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted6, with length limits
  1. full paperrticles. The format requirements are as full papers but are only up to 5 pages in length, of usually up to 1500 words with a total number of Figures plus Tables…main text ≤ 1,500 words
  2. original articlesOriginal articles are original research work/studies that are previously unpublished.Length not stated
  3. original research articlesAccepted articles are published as original research articles, short communications and reviews.Length not stated
  4. review articlesReview articles: Comprehensive, authoritative description of the subject matter within the scope of the Journal.Length not stated
  5. reviewsAccepted articles are published as original research articles, short communications and reviews.Length not stated
  6. short communicationsShort communications: report work that are preliminary in nature but merits immediate publication.Length not stated
Publisher website
Policy excerpts from the journal's websiteLicense & copyright, Open access, Peer review
License & copyright

Copyright transfer to Penerbit Universiti Sains Malaysia. Model summary

Authors transfer the copyright to Penerbit Universiti Sains Malaysia.

Source ↗Publisher website ·
Open access

Open access under CC BY 4.0. Model summary

All articles in the Journal are published open access under a Creative Commons Attribution license (CC BY 4.0).

Source ↗Publisher website ·
Peer review

Double-blind peer review policy. Model summary

This Journal practices a double-blind peer review policy.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Universiti Sains Malaysia
Country or region
Malaysia
Language
English
ISSN
1675-7319
Electronic ISSN
2180-429X
Latest issue on the website
Volume 23, Issue 2 (2025)
Official links

FAQ

Frequently asked questions about Malaysian Journal of Pharmaceutical Sciences

How long does peer review take at Malaysian Journal of Pharmaceutical Sciences?

Authors report an average review time of about 20 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Malaysian Journal of Pharmaceutical Sciences based?

Of the 23 board members whose country the journal's board page names, 1 (about 4%) are in mainland China; the countries named most often are Malaysia (9), United Kingdom (2) and Indonesia (2). Counted from the institutions listed on the board page; for reference only.

Which databases index Malaysian Journal of Pharmaceutical Sciences?

According to LetPub and DOAJ records, Malaysian Journal of Pharmaceutical Sciences is indexed in DOAJ. The journal's website also lists CAB Abstracts; that list has not been checked against each database.

Is Malaysian Journal of Pharmaceutical Sciences open access, and what is the APC?

Malaysian Journal of Pharmaceutical Sciences is a diamond open-access journal (no APC). It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .